Can an aortic dissection be treated with an esmolol (beta blocker) drip and Cardene (nicardipine) drip?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

An aortic dissection can be treated with an esmolol drip and a Cardene (nicardipine) drip as part of initial medical management, with the goal of reducing heart rate and blood pressure to decrease aortic wall stress. These medications are used to control blood pressure and heart rate, which are critical in stabilizing patients with aortic dissection. Esmolol, a short-acting beta-blocker, reduces heart rate and the force of cardiac contraction, while Cardene, a calcium channel blocker, primarily reduces blood pressure. According to the 2018 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults 1, the preferred drugs for treating acute aortic dissection are esmolol and labetalol, with the goal of rapidly lowering systolic blood pressure to ≤120 mm Hg.

Key Considerations

  • The typical target is to maintain systolic blood pressure between 100-120 mmHg and heart rate below 60 beats per minute.
  • Esmolol is typically started at 50-200 mcg/kg/min and titrated to effect, while Cardene is usually initiated at 5 mg/hr and can be increased by 2.5 mg/hr every 5-15 minutes to a maximum of 15 mg/hr.
  • These medications help reduce the shearing forces on the aortic wall, preventing extension of the dissection and allowing time for definitive treatment.

Important Notes

  • While these medications are crucial for initial stabilization, most aortic dissections (particularly Type A involving the ascending aorta) ultimately require surgical intervention, as noted in the 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease 1.
  • Type B dissections (involving only the descending aorta) may sometimes be managed medically with careful blood pressure control.

From the FDA Drug Label

7 DRUG INTERACTIONS

7.1 Antihypertensive Agents Since nicardipine hydrochloride injection may be administered to patients already being treated with other medications, including other antihypertensive agents, careful monitoring of these patients is necessary to detect and to treat promptly any undesired effects from concomitant administration. 7. 2 Beta-Blockers In most patients, nicardipine hydrochloride injection can safely be used concomitantly with beta-blockers.

The treatment of aortic dissection with an esmolol drip (a beta-blocker) and Cardene drip (nicardipine) may be considered, as the label states that nicardipine can be safely used concomitantly with beta-blockers in most patients 2. However, careful monitoring is necessary to detect and treat any undesired effects from concomitant administration.

  • Key considerations: careful monitoring of patients, potential for undesired effects
  • Main idea: concomitant use of esmolol and nicardipine may be safe in most patients, but requires careful monitoring.

From the Research

Treatment of Aortic Dissection

  • Aortic dissection is a serious and life-threatening condition that requires prompt and effective management 3, 4, 5, 6.
  • The treatment of aortic dissection involves controlling hypertension and reducing myocardial contractility, with the goal of preventing further dissection and promoting healing 7.
  • Medications used to treat aortic dissection include beta-blockers, such as esmolol, and vasodilators, such as sodium nitroprusside 3, 7.

Use of Esmolol and Cardene in Aortic Dissection

  • Esmolol, an ultrashort-acting beta-blocker, has been shown to be effective in controlling heart rate in patients with acute aortic dissection 3, 7.
  • However, there is limited information on the use of Cardene (nicardipine) in the treatment of aortic dissection.
  • The use of esmolol and Cardene in combination may be considered in certain cases, but the evidence is limited and more research is needed to fully understand their effectiveness and safety in this context.

Management of Aortic Dissection

  • The management of aortic dissection depends on the location and type of dissection, as well as the patient's overall condition 4, 5, 6.
  • Type A dissections, which involve the ascending aorta, typically require immediate surgical intervention, while Type B dissections may be managed medically or with endovascular interventions 5, 6.
  • Critical care clinicians play a key role in the diagnosis, treatment, and post-operative care of patients with aortic dissection 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Aortic dissection.

The Journal of cardiovascular nursing, 2001

Research

Management of acute aortic dissection in critical care.

Journal of the Intensive Care Society, 2023

Research

Recognition and initial management of acute aortic dissection.

British journal of hospital medicine (London, England : 2005), 2024

Research

Intravenous esmolol in acute aortic dissection.

DICP : the annals of pharmacotherapy, 1991

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.